Donald L. Trump, MD, FACP
Roswell Park Cancer Institute
Buffalo, New York
Dr. Donald Trump received his medical degree from Johns Hopkins University. He served his medical residency and was chief resident in medicine on the Osler Medical Service at The Johns Hopkins Hospital and was an oncology fellow at Johns Hopkins Oncology Center. Dr. Trump is president and CEO of the Roswell Park Cancer Institute and is a nationally recognized medical oncologist whose clinical and research programs have focused on the development of new approaches in the treatment of genitourinary cancer, especially prostate cancer.
For the past 16 years, Dr. Trump and his colleagues have focused their research efforts on the evaluation of the biologic and clinical role of vitamin D and vitamin D analogs in cancer etiology and therapeutics. He has held leadership positions in the Wisconsin Clinical Cancer Center, the Duke University Comprehensive Cancer Center, and the University of Pittsburgh Cancer Institute. In addition, he has held national leadership positions in ECOG, CALGB, ASCO and ACoS-CoC, and has served NIH study sections both as an ad hoc and permanent NIH member.
Dr. Trump has co-edited a textbook entitled Vitamin D and Cancer and has authored or co-authored more than 200 journal publications, book chapters, and abstracts. He is a reviewer and/or member of the editorial board of the New England Journal of Medicine, Journal of the National Cancer Institute, Cancer, Journal of Urologic Oncology, Clinical Cancer Research, Cure, Oncology, American Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer Research, and Journal of Clinical Oncology. Dr. Trump holds European and US patents for the use of vitamin D and vitamin D analogs in combination with high-dose chemotherapy.